Javascript must be enabled to continue!
Clinical Trials in least developed countries
View through CrossRef
Most of the conducted and organized clinical trials are ongoing in high income countries, but the number of organized clinical trials in countries with middle and low income is really low. There are many reasons for this information, however in most of the cases the the sponsors and the producers of clinical trials at the end of the trail are expecting to have clean data with clear results which can be used for determination of the end result of the clinical trial. In countries with high and with middle income this is easier to be done, due to the fact that the hospitals, institutions, or organizations in which the clinical trials are conducted have better conditions so everything can be done according to the study protocols and according to the international ethical and scientific quality standards for designing, conducting recording and reporting the clinical trials. That is one of the reasons which leads the sponsors and the organizers of clinical trials to avoid countries with low income and poverty.
Association of Practitioners of TCM Tong Da Tang TCM, Skopje
Title: Clinical Trials in least developed countries
Description:
Most of the conducted and organized clinical trials are ongoing in high income countries, but the number of organized clinical trials in countries with middle and low income is really low.
There are many reasons for this information, however in most of the cases the the sponsors and the producers of clinical trials at the end of the trail are expecting to have clean data with clear results which can be used for determination of the end result of the clinical trial.
In countries with high and with middle income this is easier to be done, due to the fact that the hospitals, institutions, or organizations in which the clinical trials are conducted have better conditions so everything can be done according to the study protocols and according to the international ethical and scientific quality standards for designing, conducting recording and reporting the clinical trials.
That is one of the reasons which leads the sponsors and the organizers of clinical trials to avoid countries with low income and poverty.
Related Results
Global Distribution and Characteristics of Research Facilities Participating in Phase III Oncology Trials
Global Distribution and Characteristics of Research Facilities Participating in Phase III Oncology Trials
ABSTRACT
Background
Research infra-structure is essential for conducting phase III cancer clinical trials as its lack precludes...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Workforce, economic, and infrastructural barriers to global oncology clinical trial participation: Focus on sub-Saharan Africa.
Workforce, economic, and infrastructural barriers to global oncology clinical trial participation: Focus on sub-Saharan Africa.
11091
Background:
Despite Sub-Saharan Africa's (SSA) growing cancer burden, the region remains grossly underrepresented in global onco...
1349. Lesson Learned from Investigators of Clinical Trials to Identify Therapeutics for COVID-19: Qualitative Study
1349. Lesson Learned from Investigators of Clinical Trials to Identify Therapeutics for COVID-19: Qualitative Study
Abstract
Background
Implementation of high-quality clinical trials especially early in the pandemic caused burden on clinical in...
Rotavirus vaccine clinical trials: a cross-sectional analysis of clinical trials registries
Rotavirus vaccine clinical trials: a cross-sectional analysis of clinical trials registries
Abstract
Background
Rotavirus is a primary infectious virus causing childhood diarrhoea and is associated with significant mortality in children. Th...
Pembrolizumab and Sarcoma: A meta-analysis
Pembrolizumab and Sarcoma: A meta-analysis
Abstract
Introduction: Pembrolizumab is a monoclonal antibody that promotes antitumor immunity. This study presents a systematic review and meta-analysis of the efficacy and safety...
Clinical trials for predictive medicine: new challenges and paradigms
Clinical trials for predictive medicine: new challenges and paradigms
Background Developments in biotechnology and genomics have increased the focus of biostatisticians on prediction problems. This has led to many exciting developments for predictive...
Variability in interventional trials in clonal haematopoiesis
Variability in interventional trials in clonal haematopoiesis
Abstract
Background Clonal haematopoiesis (CH) is an important cause of age-related diseases, characterised by the clona...

